FibroGen, Inc. (NASDAQ:FGEN) Q1 2024 Earnings Call Transcript
FibroGen, Inc. misses on earnings expectations. Reported EPS is $-0.33272 EPS, expectations were $-0.31.
No. | Hedge Fund | Shares | Value | Activity | % Port |
---|---|---|---|---|---|
1. | Armistice Capital Steven Boyd | 7,936,000 | $18,649,600 | -19% | 0.24% |
2. | Citadel Investment Group Ken Griffin | 2,013,768 | $4,732,355 | -16% | 0% |
3. | 683 Capital Partners Ari Zweiman | 1,850,000 | $4,347,500 | +165% | 0.31% |
4. | Two Sigma Advisors John Overdeck And David Siegel | 1,204,300 | $2,830,105 | -34% | 0% |
5. | Point72 Asset Management Steve Cohen | 1,080,264 | $2,538,620 | 0% |
Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
---|---|---|---|---|---|---|
$1.17 | 22,123 | 82,123 | 2024-06-12 | Filing | ||
$1.91 | 50,000 | 470,178 | 2024-03-07 | Filing | ||
$11.53 | 3,100 | Officer | 48,816 | 2021-08-26 | Filing | |
$35.28 | 19,800 | Officer, Director | 27,800 | 2020-06-11 | Filing | |
$36.29 | 8,000 | Officer, Director | 8,000 | 2020-06-10 | Filing |
Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
---|---|---|---|---|---|---|
$1.03 | 2,000 | Director | 28,866 | 2023-09-01 | Filing | |
$1.91 | 2,000 | Director | 30,866 | 2023-08-04 | Filing | |
$2.69 | 2,000 | Director | 32,866 | 2023-07-11 | Filing | |
$2.80 | 1,880 | Officer, Director | 374,722 | 2023-07-07 | Filing | |
$16.53 | 791 | Officer | 108,261 | 2023-06-23 | Filing |
No. | Name | Shares | Value | % Port |
---|---|---|---|---|
1. | 14,471,928 | $12,826,470 | 0.01% | |
2. | 7,205,300 | $6,386,058 | 0% | |
3. | 7,044,149 | $6,243,229 | 0% | |
4. | 2,489,506 | $2,206,449 | 0.01% | |
5. | 2,226,857 | $1,973,663 | 0% |